Large-scale testing (Phase 3)Looking for participantsNCT06328777
What this trial is testing
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Diseases
Cabaletta Bio 37